Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hong Kong Seeks Australian Advice On Regulating Drug Industry

This article was originally published in PharmAsia News

Executive Summary

Hong Kong health authorities have elicited the help of Australian drug experts to guide it in setting manufacturing standards for Hong Kong pharmaceuticals. The move follows a series of scandals in which tainted or unregistered drugs reached the market. In one incident, executives of Marching Pharmaceuticals were arrested after they recalled products without notifying the health department. The department's director reported the action at a meeting of the Pharmaceutical Society of Hong Kong. The head of that group said its members see no problem with the regulations already in place. (Click here for more
Advertisement

Related Content

Hong Kong Regulators Review Manufacturing, Supply Chain Regulations In Wake Of Tainted Products Leading To Six Deaths
Advertisement
UsernamePublicRestriction

Register

SC071076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel